At close: Aug 18
After Hours: 6:48PM EDT
Day High/Low36.89 - 39.75
52 Week High/Low34.88 - 145.2
Open / Close39.75 / 37.18
Float / Outstanding78M / 78.2M
Vol / Avg.5.9M / 7.4M
Mkt Cap2.9B
50d Avg. Price52.56
Div / Yield-
Payout Ratio-
Total Float78M

Novavax (NASDAQ:NVAX), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1


Highest Price Target1


Lowest Price Target1


Consensus Price Target1


Analyst Rating Summary1


Analyst Firms Making Recommendations1

  • Cowen & Co.
  • Cantor Fitzgerald
  • B of A Securities
  • B. Riley Securities
  • HC Wainwright & Co.

1calculated from analyst ratings published within the last 6 months

Analyst Ratings for Novavax

All Ratings (0)

Upgrades (0)

Downgrades (0)

Initiations (0)

Analyst Firm
Price Target Change
Rating Change
Previous / Current Rating
Get Alert

Novavax Questions & Answers

What is the target price for Novavax (NVAX)?

The latest price target for Novavax (NASDAQ: NVAX) was reported by Cowen & Co. on August 9, 2022. The analyst firm set a price target for $110.00 expecting NVAX to rise to within 12 months (a possible 195.86% upside). 7 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Novavax (NVAX)?

The latest analyst rating for Novavax (NASDAQ: NVAX) was provided by Cowen & Co., and Novavax maintained their outperform rating.

When is the next analyst rating going to be posted or updated for Novavax (NVAX)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Novavax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Novavax was filed on August 9, 2022 so you should expect the next rating to be made available sometime around August 9, 2023.

Is the Analyst Rating Novavax (NVAX) correct?

While ratings are subjective and will change, the latest Novavax (NVAX) rating was a maintained with a price target of $150.00 to $110.00. The current price Novavax (NVAX) is trading at is $37.18, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.